TY - JOUR
T1 - The COVID-19 pandemic: diverse contexts; different epidemics-how and why?
AU - Van Damme, Wim
AU - Dahake, Ritwik
AU - Delamou, Alexandre
AU - Ingelbeen, Brecht
AU - Wouters, Edwin
AU - Vanham, Guido
AU - van de Pas, Remco
AU - Dossou, Jean-Paul
AU - Ir, Por
AU - Abimbola, Seye
AU - Van der Borght, Stefaan
AU - Narayanan, Devadasan
AU - Bloom, Gerald
AU - Van Engelgem, Ian
AU - Ag Ahmed, Mohamed Ali
AU - Kiendrébéogo, Joël Arthur
AU - Verdonck, Kristien
AU - De Brouwere, Vincent
AU - Bello, Kéfilath
AU - Kloos, Helmut
AU - Aaby, Peter
AU - Kalk, Andreas
AU - Al-Awlaqi, Sameh
AU - Prashanth, N S
AU - Muyembe-Tamfum, Jean-Jacques
AU - Mbala, Placide
AU - Ahuka-Mundeke, Steve
AU - Assefa, Yibeltal
N1 - FTX; DOAJ; (CC BY-NC 4.0)
PY - 2020
Y1 - 2020
N2 - It is very exceptional that a new disease becomes a true pandemic. Since its emergence in Wuhan, China, in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, has spread to nearly all countries of the world in only a few months. However, in different countries, the COVID-19 epidemic takes variable shapes and forms in how it affects communities. Until now, the insights gained on COVID-19 have been largely dominated by the COVID-19 epidemics and the lockdowns in China, Europe and the USA. But this variety of global trajectories is little described, analysed or understood. In only a few months, an enormous amount of scientific evidence on SARS-CoV-2 and COVID-19 has been uncovered (knowns). But important knowledge gaps remain (unknowns). Learning from the variety of ways the COVID-19 epidemic is unfolding across the globe can potentially contribute to solving the COVID-19 puzzle. This paper tries to make sense of this variability-by exploring the important role that context plays in these different COVID-19 epidemics; by comparing COVID-19 epidemics with other respiratory diseases, including other coronaviruses that circulate continuously; and by highlighting the critical unknowns and uncertainties that remain. These unknowns and uncertainties require a deeper understanding of the variable trajectories of COVID-19. Unravelling them will be important for discerning potential future scenarios, such as the first wave in virgin territories still untouched by COVID-19 and for future waves elsewhere.
AB - It is very exceptional that a new disease becomes a true pandemic. Since its emergence in Wuhan, China, in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, has spread to nearly all countries of the world in only a few months. However, in different countries, the COVID-19 epidemic takes variable shapes and forms in how it affects communities. Until now, the insights gained on COVID-19 have been largely dominated by the COVID-19 epidemics and the lockdowns in China, Europe and the USA. But this variety of global trajectories is little described, analysed or understood. In only a few months, an enormous amount of scientific evidence on SARS-CoV-2 and COVID-19 has been uncovered (knowns). But important knowledge gaps remain (unknowns). Learning from the variety of ways the COVID-19 epidemic is unfolding across the globe can potentially contribute to solving the COVID-19 puzzle. This paper tries to make sense of this variability-by exploring the important role that context plays in these different COVID-19 epidemics; by comparing COVID-19 epidemics with other respiratory diseases, including other coronaviruses that circulate continuously; and by highlighting the critical unknowns and uncertainties that remain. These unknowns and uncertainties require a deeper understanding of the variable trajectories of COVID-19. Unravelling them will be important for discerning potential future scenarios, such as the first wave in virgin territories still untouched by COVID-19 and for future waves elsewhere.
U2 - 10.1136/bmjgh-2020-003098
DO - 10.1136/bmjgh-2020-003098
M3 - A1: Web of Science-article
C2 - 32718950
SN - 2059-7908
VL - 5
JO - BMJ Global Health
JF - BMJ Global Health
IS - 7
ER -